<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/static_images/rss2full.xsl" type="text/xsl" media="screen"?>

<?xml-stylesheet href="/static_images/itemcontent.css" type="text/css" media="screen"?>

<rss version="2.0">
    <channel>
        <title>Infection Control Nurses  - Clinical News - RSS Feed</title>
        <link>http://www.nursingtimes.net/RSS/Infection_control_nurses_Clinical_News_RSS_Feed.xml</link>
        <language>en-uk</language>
	<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" href="http://feeds.feedburner.com/RSS/Infection_control_nurses_Clinical_News_RSS_Feed" rel="self" type="application/rss+xml"/>
            <item>
                <title>Asthma jab gains approval</title>
        <description>NICE has approved omalizumab (Xolair), a fortnightly injection that could halve acute exacerbations of allergic asthma in adults and children over 12 years.</description>
                <link>http://www.nursingtimes.net:80/Clinical_journal_round_up/asthma_jab_gains_approval.html;jsessionid=E5EAA6733641810416B38988711E433A</link>
                <author>Clare Lomas</author>
                <pubDate>03 December 2007 12:16</pubDate>
            </item>
<item>
                <title>Diabetes drugs worth the risks</title>
        <description>EUROPEAN drug regulators have said the benefits of diabetes drugs rosiglitazone and pioglitazone outweigh any potential cardiovascular risks, despite recent research.
</description>
                <link>http://www.nursingtimes.net:80/This_weeks_issue/diabetes_drugs_worth_the_risks.html;jsessionid=E5EAA6733641810416B38988711E433A</link>
                <guid>http://www.nursingtimes.net:80/This_weeks_issue/diabetes_drugs_worth_the_risks.html;jsessionid=E5EAA6733641810416B38988711E433A</guid>
                <author>Steve Ford</author>
                <pubDate>05 November 2007 16:03</pubDate>
            </item>
<item>
                <title>MRSA and C. diff rates show downward trend</title>
        <description>THE NUMBER of patients in England infected with MRSA has fallen by 10% in the last year, while Clostridium difficile rates also appear to be levelling out, latest official figures show.</description>
                <link>http://www.nursingtimes.net:80/This_weeks_issue/mrsa_and_c_diff_rates_show_downward_trend.html;jsessionid=E5EAA6733641810416B38988711E433A</link>
                <guid>http://www.nursingtimes.net:80/This_weeks_issue/mrsa_and_c_diff_rates_show_downward_trend.html;jsessionid=E5EAA6733641810416B38988711E433A</guid>
                <author>Clare Lomas</author>
                <pubDate>05 November 2007 16:06</pubDate>
            </item>
<item>
                <title>HCAIs incidence in nursing homes</title>
        <description>Urinary tract infections are the most frequently diagnosed healthcare-acquired infections among residents in nursing homes, Norwegian research suggests.</description>
                <link>http://www.nursingtimes.net:80/clinicalnews/hcais_incidence_in_nursing_homes.html;jsessionid=E5EAA6733641810416B38988711E433A</link>
                <author/>
                <pubDate>07 February 2007 09:30</pubDate>
            </item>
<item>
                <title>Free research archive goes online</title>
        <description>Around 600,000 peer-reviewed research papers were made available free over the internet this week with the launch of UK PubMed Central.</description>
                <link>http://www.nursingtimes.net:80/mentalhealthnurses/clinicalnews/free_research_archive_goes_online.html;jsessionid=E5EAA6733641810416B38988711E433A</link>
                <author/>
                <pubDate>15 January 2007 10:22</pubDate>
            </item>
<item>
                <title>Nurses could be disciplined for drinking patients' tea</title>
        <description>NURSES at a London hospital could face disciplinary action for drinking cups of tea from ward trolleys.</description>
                <link>http://www.nursingtimes.net:80/clinicalnews/nurses_could_be_disciplined_for_drinking_patients_tea.html;jsessionid=E5EAA6733641810416B38988711E433A</link>
                <author/>
                <pubDate>02 January 2007 11:54</pubDate>
            </item>
<item>
                <title>Patients to lose inhaled insulin choice</title>
        <description>PATIENTS with diabetes look set to lose access to the inhaled insulin product Exubera, after Pfizer announced it was ceasing production.</description>
                <link>http://www.nursingtimes.net:80/clinicalnews/patients_to_lose_inhaled_insulin_choice.html;jsessionid=E5EAA6733641810416B38988711E433A</link>
                <author>Steve Ford</author>
                <pubDate>29 October 2007 16:08</pubDate>
            </item>
<item>
                <title>Extra methadone reward 'unethical'</title>
        <description>DRUG misusers who provide a clean urine sample are being wrongly rewarded with increased doses of methadone, according to reports.</description>
                <link>http://www.nursingtimes.net:80/clinicalnews/extra_methadone_reward_unethical.html;jsessionid=E5EAA6733641810416B38988711E433A</link>
                <author>Steve Ford</author>
                <pubDate>29 October 2007 15:59</pubDate>
            </item>
    </channel>
</rss>
